Overexpressed LAPTM4B-35 Is a Risk Factor for Cancer Recurrence and Poor Prognosis in Non-Small-Cell Lung Cancer

Oncotarget - United States
doi 10.18632/oncotarget.10907
Full Text
Abstract

Available in full text

Categories
Oncology
Date
Authors
Publisher

Impact Journals, LLC

Related search

Nociceptin Receptor Is Overexpressed in Non-Small Cell Lung Cancer and Predicts Poor Prognosis

Frontiers in Oncology
Cancer ResearchOncology
2019English

SCUBE3 Overexpression Predicts Poor Prognosis in Non-Small Cell Lung Cancer

BioScience Trends
BiochemistryHealthMedicineGeneticsMolecular Biology
2013English

Small Ubiquitin-Like Modifier/Sentrin-Specific Peptidase 1 Associates With Chemotherapy and Is a Risk Factor for Poor Prognosis of Non-Small Cell Lung Cancer

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2018English

Overexpression of LAPTM4B-35: A Novel Marker of Poor Prognosis of Prostate Cancer

PLoS ONE
Multidisciplinary
2014English

LINK‑A lncRNA Is Upregulated in Metastatic Non‑small Cell Lung Cancer and Is Associated With Poor Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Upregulated Expression of miR-421 Is Associated With Poor Prognosis in Non-Small-Cell Lung Cancer

Cancer Management and Research
Oncology
2018English

PED Is Overexpressed and Mediates TRAIL Resistance in Human Non-Small Cell Lung Cancer

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2008English

Low Level of 5-Hydroxymethylcytosine Predicts Poor Prognosis in Non-Small Cell Lung Cancer

Oncology Letters
Cancer ResearchOncology
2016English

A Chromosomal Passenger Complex Protein Signature Model Predicts Poor Prognosis For non-Small-Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy